Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

NCT00424814 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

105

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Kaletra (lopinavir/ritonavir)
DRUG: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]